Source link : https://www.newshealth.biz/health-news/biomarkers-predict-lung-disease-outcome-in-ssc-ild-therapy/
TOPLINE: Changes in Krebs von den Lungen 6 (KL-6) levels after 12 months of treatment with mycophenolate mofetil (MMF) or cyclophosphamide (CYC) are associated with the development of progressive pulmonary fibrosis (PPF) in patients with systemic sclerosis–associated interstitial lung disease (SSc-ILD) in the following year. METHODOLOGY: Despite available treatments, about 25% of patients with SSc-ILD […]
Author : News Health
Publish date : 2025-01-09 10:04:01
Copyright for syndicated content belongs to the linked Source.
Categories